S 207 115th Congress Senate Crime and Law Enforcement Drug trafficking and controlled substances Drug, alcohol, tobacco use Evidence and witnesses Marketing and advertising

SALTS Act

Introduced: January 24, 2017 Introduced by: Klobuchar, Amy Democratic · Minnesota See on congress.gov

Everywhere this bill has been 6 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 19, 2018

Placed on Senate Legislative Calendar under General Orders. Calendar No. 472.

Jun 19, 2018

Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

May 24, 2018

Committee on the Judiciary. Ordered to be reported without amendment favorably.

Apr 11, 2018

Committee on the Judiciary Subcommittee on Crime and Terrorism. Hearings held.

Jan 24, 2017

Read twice and referred to the Committee on the Judiciary.

Jan 24, 2017

Introduced in Senate

Plain-English summary Congressional Research Service

Synthetic Abuse and Labeling of Toxic Substances Act of 2017 or the SALTS Act

(Sec. 2) This bill amends the Controlled Substances Act to set forth factors that may be considered as evidence to determine whether a controlled substance analogue is intended for human consumption. (Under current law, a controlled substance analogue that is intended for human consumption is treated as a schedule I controlled substance. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)

What's happening now June 19, 2018

Placed on Senate Legislative Calendar under General Orders. Calendar No. 472.

Committees of jurisdiction 2